Intelligent Medicine Exchange (IMX)’s Post

Our 2024 Mid-Year Technology and Life Sciences PIPE and Registered Direct Offerings Report is out. Some interesting nuggets include a solid increase in 1H life sciences transaction count compared to same period prior year, flat transaction count for tech companies and pricing that is becoming more company favorable. Despite market volatility, high interest rates, and ongoing geopolitical conflicts, IPO and new issue markets are gradually reopening. However, due to the upcoming U.S. presidential election, companies might continue to explore alternatives to traditional underwritten offerings to meet their financing needs.

A must-read report! Life science is set to play a major part in the M&A upswing we’re predicting for 2024 — with a new set of game-changing opportunities open to key players in the sector. Check out the full outlook and strategic guide in the EY 2024 Firepower report: https://lnkd.in/eZ6ZEvmZ

Check out our latest take on the state of the life science services market, where Edgemont Partners remains active on the M&A advisory front. More analysis to come on one particularly hot pocket of the market!

Site operators, you should probably pay attention to this, especially this part... ·Clinicalresearch sitesector remains highly fragmented, with the top platforms commanding only ~15% of the overall marketshare. ·Sponsor-backed platforms and large industry incumbents have driven recent consolidation, with ~30 consolidators of scale in the market now. ·COVID-19 pandemic accelerated site consolidation. ·Strong industrial logic for large, scaled platforms, as life science sponsors increasingly prefer efficient and well-professionalized providers that can more readily access diverse and distributed patient populations, accelerate patient recruitment and enrollment, and ensure consistent and accurate data collection. #RiseOfTheSites

Dive into the details of The Latest on Securities Class Actions in Life Sciences report to gain valuable insights into the top five settlements and nuances of these class action suits. My colleague Priya Cherian Huskins navigates the complex landscape of securities class actions in the Life Sciences sector.

Dive into the details of The Latest on Securities Class Actions in Life Sciences report to gain valuable insights into the top five settlements and nuances of these class action suits. My colleague Priya Cherian Huskins navigates the complex landscape of securities class actions in the Life Sciences sector.

Dive into the details of The Latest on Securities Class Actions in Life Sciences report to gain valuable insights into the top five settlements and nuances of these class action suits. My colleague Priya Cherian Huskins navigates the complex landscape of securities class actions in the Life Sciences sector.

Dive into the details of The Latest on Securities Class Actions in Life Sciences report to gain valuable insights into the top five settlements and nuances of these class action suits. My colleague Priya Cherian Huskins navigates the complex landscape of securities class actions in the Life Sciences sector.

Dive into the details of The Latest on Securities Class Actions in Life Sciences report to gain valuable insights into the top five settlements and nuances of these class action suits. My Woodruff Sawyer colleague Priya Cherian Huskins navigates the complex landscape of securities class actions in the Life Sciences sector. #directorsandofficers

Blue Mountain and Quantus, Inc are excited to announce we are hosting a free webinar on "Calibration Program Best Practices" on June 13th at 10 AM EDT. Register here to attend: https://lnkd.in/e27GrAqy . Establishing and maintaining a robust calibration program in the life sciences industry is essential for the production of high quality, safe, and compliant products. In this webinar, attendees will learn about the fundamental structure of a compliant program, which includes establishing procedures, performing and documenting actions, and approving compliance actions. Register here: https://lnkd.in/e27GrAqy . #BlueMountainRAM #GMPDigitalMaturtityModel #RegulatoryAssetManager #AdvanceGMPcompliance